MET and hepatocellular carcinoma: HCC is a genetically heterogeneous malignancy in which numerous deregulated signaling pathways lead to elevated proliferation and angiogenesis, including RAF/MEK/ERK, PI3K/AKT/mTOR, WNT/β-catenin, IGF, and HGF/c-MET [2].